The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21.20 - Manufacture of pharmaceutical preparations
150 jobs Number of planned job losses
Announcement Date
13 November 2025
Employment effect (start)
13 November 2025
Foreseen end date
Description
The German medical diagnostics company Euroimmun Medizinische Labordiagnostika plans to cut 150 jobs in Germany. The northern sites in Lübeck, Groß Grönau, and Selmsdorf will be affected. The Saxon sites in Bernstadt and Rennersdorf will not be affected.
According to the company, capacities need to be adjusted because demand in the areas of automation and mechanical engineering has declined. According to the company, the positions are to be reduced in a socially responsible manner, primarily through severance packages and transitions into retirement, with only a few layoffs.
Euroimmun is a manufacturer of medical laboratory diagnostics and develops tests, devices, and software for detecting autoimmune, infectious, and allergy-related diseases. It was sold to the U.S. corporation PerkinElmer in 2018 (since 2023 Revvity). Euroimmun operates worldwide and employs 3,400 people in 17 countries.